Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution

Exclusion Criteria

• •A history of current or recurrent disease that could have an effect on the study
• •Subject has a history of seizures, any tic disorder, or a current diagnosis and/or a known family history of Tourette's Disorder
• •Subject has a concurrent chronic or acute illness or other condition that might confound the results of safety assessments or that might increase risk to the subject
• •Subject has any clinically significant ECG and/or laboratory abnormalities
• •Subject has a documented allergy, hypersensitivity or intolerance to amphetamines
• •Subject has been prescribed or has taken amphetamine products in the past, including childhood; recreational use may not be exclusionary per the Investigator's discretion
• •Subject has a known family history of sudden cardiac death or ventricular arrhythmia
• •Subject has a recent history (within the past 6 months) of suspected substance abuse or dependence disorder (excluding nicotine)
• •Subject has participated in any investigational clinical or vaccine trial within 30 days prior to the first dose of study drug
• •Subjects is currently considered a suicide risk, has previously made a suicide attempt or has a prior history of, or is currently demonstrating suicidal ideation